| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE | 18 |
| 1 | PREDNISOLONE | 18 |
| 2 | PREDNISOLONE ORAL | 18 |
| 3 | PREDNISOLONE ORAL SOLUTION | 18 |
| 4 | TAPENTADOL HYDROCHLORIDE | 18 |
| 5 | EFAVIRENZ | 17 |
| 6 | ROSUVASTATIN | 16 |
| 7 | TIOTROPIUM BROMIDE | 11 |
| 8 | ERGOCALCIFEROL | 10 |
| 9 | LEVOTHYROXINE SODIUM | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EFAVIRENZ | 17 | 0.0015 |
| 1 | LAROTRECTINIB | 1 | 0.0011 |
| 2 | TAPENTADOL HYDROCHLORIDE | 18 | 0.0005 |
| 3 | ERGOCALCIFEROL | 10 | 0.0003 |
| 4 | ROSUVASTATIN | 16 | 0.0002 |
| 5 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 2 | 0.0002 |
| 6 | KETOPROFEN | 2 | 0.0001 |
| 7 | PREDNISOLONE ORAL SOLUTION | 18 | 0.0001 |
| 8 | ASFOTASE ALFA | 1 | 0.0001 |
| 9 | TIOTROPIUM BROMIDE | 11 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 17 | 0.0007 |
| 1 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 2 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 16 | 0.0000 |
| 4 | Central alpha-2 Adrenergic Agonist [EPC] | 2 | 0.0000 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Corticosteroid [EPC] | 19 | 0.0000 |
| 7 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 9 | Progestin [EPC] | 1 | 0.0000 |